APO Research
Talk to an analyst

APO RESEARCH · REPORT

Coccidiosis Vaccines in Chickens

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Coccidiosis Vaccines in Chickens Market Outlook and Growth Opportunities 2026

2 January 2026190 pages

Choose your research edition.

Industry ResearchCoccidiosis Vaccines in Chickens Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Coccidiosis Vaccines in Chickens Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Coccidiosis Vaccines in Chickens Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Coccidiosis Vaccines in Chickens Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Coccidiosis Vaccines in Chickens Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Coccidiosis Vaccines in Chickens market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Coccidiosis Vaccines in Chickens is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Coccidiosis Vaccines in Chickens is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Coccidiosis Vaccines in Chickens is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Coccidiosis Vaccines in Chickens market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Coccidiosis Vaccines in Chickens market include Biopharm, Bioproperties, Boehringer Ingelheim, Ceva Santé Animale, HIPRA, Huvepharma, MSD Animal Health, Nisseiken and Vaxxinova, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Coccidiosis Vaccines in Chickens market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Coccidiosis Vaccines in Chickens and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Coccidiosis Vaccines in Chickens sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Coccidiosis Vaccines in Chickens market size, projected growth trends, production technologies, key applications, and end-use industries.

Coccidiosis Vaccines in Chickens Segment by Company

Biopharm

Bioproperties

Boehringer Ingelheim

Ceva Santé Animale

HIPRA

Huvepharma

MSD Animal Health

Nisseiken

Vaxxinova

Foshan Standard Biotech

Hlinte

Qilu Qingda Bio-Pharmaceutical

Skystar Bio-pharm

Guangdong Winsun Bio-pharmaceutical

Coccidiosis Vaccines in Chickens Segment by Type

Attenuated Vaccines

Non-attenuated Vaccines

Coccidiosis Vaccines in Chickens Segment by Application

Layers

Turkeys

Broilers

Breeders

Coccidiosis Vaccines in Chickens Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Coccidiosis Vaccines in Chickens status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Coccidiosis Vaccines in Chickens market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Coccidiosis Vaccines in Chickens significant trends, drivers, influence factors in global and regions.

6. To analyze Coccidiosis Vaccines in Chickens competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coccidiosis Vaccines in Chickens market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Coccidiosis Vaccines in Chickens and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coccidiosis Vaccines in Chickens.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Coccidiosis Vaccines in Chickens market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Coccidiosis Vaccines in Chickens industry.

Chapter 3: Detailed analysis of Coccidiosis Vaccines in Chickens manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Coccidiosis Vaccines in Chickens in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Coccidiosis Vaccines in Chickens in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Coccidiosis Vaccines in Chickens Industry Trends Table 2. Coccidiosis Vaccines in Chickens Industry Drivers Table 3. Coccidiosis Vaccines in Chickens Industry Opportunities and Challenges Table 4. Coccidiosis Vaccines in Chickens Industry Restraints Table 5. Global Coccidiosis Vaccines in Chickens Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Coccidiosis Vaccines in Chickens Revenue Share by Company (2021-2026) Table 7. Global Coccidiosis Vaccines in Chickens Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Coccidiosis Vaccines in Chickens Sales Volume Share by Company (2021-2026) Table 9. Global Coccidiosis Vaccines in Chickens Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Coccidiosis Vaccines in Chickens Company Ranking, (2024-2026) & (USD Million) Table 11. Global Coccidiosis Vaccines in Chickens Key Company Manufacturing Base & Headquarters Table 12. Global Coccidiosis Vaccines in Chickens Company, Product Type & Application Table 13. Global Coccidiosis Vaccines in Chickens Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Coccidiosis Vaccines in Chickens by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Attenuated Vaccines Table 18. Significant Companies of Non-attenuated Vaccines Table 19. Global Coccidiosis Vaccines in Chickens Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Coccidiosis Vaccines in Chickens Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Coccidiosis Vaccines in Chickens Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Coccidiosis Vaccines in Chickens Sales Volume Share by Type (2021-2026) Table 23. Global Coccidiosis Vaccines in Chickens Sales Volume Share by Type (2027-2032) Table 24. Global Coccidiosis Vaccines in Chickens Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Coccidiosis Vaccines in Chickens Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Coccidiosis Vaccines in Chickens Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Coccidiosis Vaccines in Chickens Sales Value Share by Type (2021-2026) Table 28. Global Coccidiosis Vaccines in Chickens Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Layers Table 30. Significant Companies of Turkeys Table 31. Significant Companies of Broilers Table 32. Significant Companies of Breeders Table 33. Global Coccidiosis Vaccines in Chickens Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Coccidiosis Vaccines in Chickens Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Coccidiosis Vaccines in Chickens Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Coccidiosis Vaccines in Chickens Sales Volume Share by Application (2021-2026) Table 37. Global Coccidiosis Vaccines in Chickens Sales Volume Share by Application (2027-2032) Table 38. Global Coccidiosis Vaccines in Chickens Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Coccidiosis Vaccines in Chickens Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Coccidiosis Vaccines in Chickens Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Coccidiosis Vaccines in Chickens Sales Value Share by Application (2021-2026) Table 42. Global Coccidiosis Vaccines in Chickens Sales Value Share by Application (2027-2032) Table 43. Global Coccidiosis Vaccines in Chickens Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Coccidiosis Vaccines in Chickens Sales by Region (2021-2026) & (K Units) Table 45. Global Coccidiosis Vaccines in Chickens Sales Market Share by Region (2021-2026) Table 46. Global Coccidiosis Vaccines in Chickens Sales by Region (2027-2032) & (K Units) Table 47. Global Coccidiosis Vaccines in Chickens Sales Market Share by Region (2027-2032) Table 48. Global Coccidiosis Vaccines in Chickens Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Coccidiosis Vaccines in Chickens Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Coccidiosis Vaccines in Chickens Sales Value Share by Region (2021-2026) Table 51. Global Coccidiosis Vaccines in Chickens Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Coccidiosis Vaccines in Chickens Sales Value Share by Region (2027-2032) Table 53. Global Coccidiosis Vaccines in Chickens Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Coccidiosis Vaccines in Chickens Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Coccidiosis Vaccines in Chickens Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Coccidiosis Vaccines in Chickens Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Coccidiosis Vaccines in Chickens Sales by Country (2021-2026) & (K Units) Table 58. Global Coccidiosis Vaccines in Chickens Sales Market Share by Country (2021-2026) Table 59. Global Coccidiosis Vaccines in Chickens Sales by Country (2027-2032) & (K Units) Table 60. Global Coccidiosis Vaccines in Chickens Sales Market Share by Country (2027-2032) Table 61. Global Coccidiosis Vaccines in Chickens Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Coccidiosis Vaccines in Chickens Sales Value Market Share by Country (2021-2026) Table 63. Global Coccidiosis Vaccines in Chickens Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Coccidiosis Vaccines in Chickens Sales Value Market Share by Country (2027-2032) Table 65. Biopharm Company Information Table 66. Biopharm Business Overview Table 67. Biopharm Coccidiosis Vaccines in Chickens Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Biopharm Coccidiosis Vaccines in Chickens Product Portfolio Table 69. Biopharm Recent Development Table 70. Bioproperties Company Information Table 71. Bioproperties Business Overview Table 72. Bioproperties Coccidiosis Vaccines in Chickens Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Bioproperties Coccidiosis Vaccines in Chickens Product Portfolio Table 74. Bioproperties Recent Development Table 75. Boehringer Ingelheim Company Information Table 76. Boehringer Ingelheim Business Overview Table 77. Boehringer Ingelheim Coccidiosis Vaccines in Chickens Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Boehringer Ingelheim Coccidiosis Vaccines in Chickens Product Portfolio Table 79. Boehringer Ingelheim Recent Development Table 80. Ceva Santé Animale Company Information Table 81. Ceva Santé Animale Business Overview Table 82. Ceva Santé Animale Coccidiosis Vaccines in Chickens Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Ceva Santé Animale Coccidiosis Vaccines in Chickens Product Portfolio Table 84. Ceva Santé Animale Recent Development Table 85. HIPRA Company Information Table 86. HIPRA Business Overview Table 87. HIPRA Coccidiosis Vaccines in Chickens Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. HIPRA Coccidiosis Vaccines in Chickens Product Portfolio Table 89. HIPRA Recent Development Table 90. Huvepharma Company Information Table 91. Huvepharma Business Overview Table 92. Huvepharma Coccidiosis Vaccines in Chickens Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Huvepharma Coccidiosis Vaccines in Chickens Product Portfolio Table 94. Huvepharma Recent Development Table 95. MSD Animal Health Company Information Table 96. MSD Animal Health Business Overview Table 97. MSD Animal Health Coccidiosis Vaccines in Chickens Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. MSD Animal Health Coccidiosis Vaccines in Chickens Product Portfolio Table 99. MSD Animal Health Recent Development Table 100. Nisseiken Company Information Table 101. Nisseiken Business Overview Table 102. Nisseiken Coccidiosis Vaccines in Chickens Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Nisseiken Coccidiosis Vaccines in Chickens Product Portfolio Table 104. Nisseiken Recent Development Table 105. Vaxxinova Company Information Table 106. Vaxxinova Business Overview Table 107. Vaxxinova Coccidiosis Vaccines in Chickens Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Vaxxinova Coccidiosis Vaccines in Chickens Product Portfolio Table 109. Vaxxinova Recent Development Table 110. Foshan Standard Biotech Company Information Table 111. Foshan Standard Biotech Business Overview Table 112. Foshan Standard Biotech Coccidiosis Vaccines in Chickens Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Foshan Standard Biotech Coccidiosis Vaccines in Chickens Product Portfolio Table 114. Foshan Standard Biotech Recent Development Table 115. Hlinte Company Information Table 116. Hlinte Business Overview Table 117. Hlinte Coccidiosis Vaccines in Chickens Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Hlinte Coccidiosis Vaccines in Chickens Product Portfolio Table 119. Hlinte Recent Development Table 120. Qilu Qingda Bio-Pharmaceutical Company Information Table 121. Qilu Qingda Bio-Pharmaceutical Business Overview Table 122. Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines in Chickens Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines in Chickens Product Portfolio Table 124. Qilu Qingda Bio-Pharmaceutical Recent Development Table 125. Skystar Bio-pharm Company Information Table 126. Skystar Bio-pharm Business Overview Table 127. Skystar Bio-pharm Coccidiosis Vaccines in Chickens Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Skystar Bio-pharm Coccidiosis Vaccines in Chickens Product Portfolio Table 129. Skystar Bio-pharm Recent Development Table 130. Guangdong Winsun Bio-pharmaceutical Company Information Table 131. Guangdong Winsun Bio-pharmaceutical Business Overview Table 132. Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines in Chickens Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines in Chickens Product Portfolio Table 134. Guangdong Winsun Bio-pharmaceutical Recent Development Table 135. Key Raw Materials Table 136. Raw Materials Key Suppliers Table 137. Coccidiosis Vaccines in Chickens Distributors List Table 138. Coccidiosis Vaccines in Chickens Customers List Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Coccidiosis Vaccines in Chickens Product Image Figure 2. Global Coccidiosis Vaccines in Chickens Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Coccidiosis Vaccines in Chickens Sales Value (2021-2032) & (US$ Million) Figure 4. Global Coccidiosis Vaccines in Chickens Sales (2021-2032) & (K Units) Figure 5. Global Coccidiosis Vaccines in Chickens Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Coccidiosis Vaccines in Chickens Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Attenuated Vaccines Image Figure 10. Non-attenuated Vaccines Image Figure 11. Global Coccidiosis Vaccines in Chickens Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Coccidiosis Vaccines in Chickens Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Coccidiosis Vaccines in Chickens Sales Volume Share by Type (2021-2032) Figure 14. Global Coccidiosis Vaccines in Chickens Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Coccidiosis Vaccines in Chickens Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Coccidiosis Vaccines in Chickens Sales Value Share by Type (2021-2032) Figure 17. Layers Image Figure 18. Turkeys Image Figure 19. Broilers Image Figure 20. Breeders Image Figure 21. Global Coccidiosis Vaccines in Chickens Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Coccidiosis Vaccines in Chickens Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Coccidiosis Vaccines in Chickens Sales Volume Share by Application (2021-2032) Figure 24. Global Coccidiosis Vaccines in Chickens Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Coccidiosis Vaccines in Chickens Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Coccidiosis Vaccines in Chickens Sales Value Share by Application (2021-2032) Figure 27. Global Coccidiosis Vaccines in Chickens Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Coccidiosis Vaccines in Chickens Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Coccidiosis Vaccines in Chickens Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Coccidiosis Vaccines in Chickens Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Coccidiosis Vaccines in Chickens Sales Value (2021-2032) & (US$ Million) Figure 32. North America Coccidiosis Vaccines in Chickens Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Coccidiosis Vaccines in Chickens Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Coccidiosis Vaccines in Chickens Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Coccidiosis Vaccines in Chickens Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Coccidiosis Vaccines in Chickens Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Coccidiosis Vaccines in Chickens Sales Value (2021-2032) & (US$ Million) Figure 38. South America Coccidiosis Vaccines in Chickens Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Coccidiosis Vaccines in Chickens Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Coccidiosis Vaccines in Chickens Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Coccidiosis Vaccines in Chickens Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Coccidiosis Vaccines in Chickens Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Attenuated Vaccines
  • Non-attenuated Vaccines
Applications
  • Layers
  • Turkeys
  • Broilers
  • Breeders
Companies covered
  • Biopharm
  • Bioproperties
  • Boehringer Ingelheim
  • Ceva Santé Animale
  • HIPRA
  • Huvepharma
  • MSD Animal Health
  • Nisseiken
  • Vaxxinova
  • Foshan Standard Biotech
  • Hlinte
  • Qilu Qingda Bio-Pharmaceutical
  • Skystar Bio-pharm
  • Guangdong Winsun Bio-pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Coccidiosis Vaccines in Chickens Sales Value (2021-2032)
  4. 1.2.2 Global Coccidiosis Vaccines in Chickens Sales Volume (2021-2032)
  5. 1.2.3 Global Coccidiosis Vaccines in Chickens Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Coccidiosis Vaccines in Chickens Market Dynamics
  1. 2.1 Coccidiosis Vaccines in Chickens Industry Trends
  2. 2.2 Coccidiosis Vaccines in Chickens Industry Drivers
  3. 2.3 Coccidiosis Vaccines in Chickens Industry Opportunities and Challenges
  4. 2.4 Coccidiosis Vaccines in Chickens Industry Restraints
3 Coccidiosis Vaccines in Chickens Market by Company
  1. 3.1 Global Coccidiosis Vaccines in Chickens Company Revenue Ranking in 2025
  2. 3.2 Global Coccidiosis Vaccines in Chickens Revenue by Company (2021-2026)
  3. 3.3 Global Coccidiosis Vaccines in Chickens Sales Volume by Company (2021-2026)
  4. 3.4 Global Coccidiosis Vaccines in Chickens Average Price by Company (2021-2026)
  5. 3.5 Global Coccidiosis Vaccines in Chickens Company Ranking (2024-2026)
  6. 3.6 Global Coccidiosis Vaccines in Chickens Company Manufacturing Base and Headquarters
  7. 3.7 Global Coccidiosis Vaccines in Chickens Company Product Type and Application
  8. 3.8 Global Coccidiosis Vaccines in Chickens Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Coccidiosis Vaccines in Chickens Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Coccidiosis Vaccines in Chickens Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Coccidiosis Vaccines in Chickens Market by Type
  1. 4.1 Coccidiosis Vaccines in Chickens Type Introduction
  2. 4.1.1 Attenuated Vaccines
  3. 4.1.2 Non-attenuated Vaccines
  4. 4.2 Global Coccidiosis Vaccines in Chickens Sales Volume by Type
  5. 4.2.1 Global Coccidiosis Vaccines in Chickens Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Coccidiosis Vaccines in Chickens Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Coccidiosis Vaccines in Chickens Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Coccidiosis Vaccines in Chickens Sales Value by Type
  9. 4.3.1 Global Coccidiosis Vaccines in Chickens Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Coccidiosis Vaccines in Chickens Sales Value by Type (2021-2032)
  11. 4.3.3 Global Coccidiosis Vaccines in Chickens Sales Value Share by Type (2021-2032)
5 Coccidiosis Vaccines in Chickens Market by Application
  1. 5.1 Coccidiosis Vaccines in Chickens Application Introduction
  2. 5.1.1 Layers
  3. 5.1.2 Turkeys
  4. 5.1.3 Broilers
  5. 5.1.4 Breeders
  6. 5.2 Global Coccidiosis Vaccines in Chickens Sales Volume by Application
  7. 5.2.1 Global Coccidiosis Vaccines in Chickens Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Coccidiosis Vaccines in Chickens Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Coccidiosis Vaccines in Chickens Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Coccidiosis Vaccines in Chickens Sales Value by Application
  11. 5.3.1 Global Coccidiosis Vaccines in Chickens Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Coccidiosis Vaccines in Chickens Sales Value by Application (2021-2032)
  13. 5.3.3 Global Coccidiosis Vaccines in Chickens Sales Value Share by Application (2021-2032)
6 Coccidiosis Vaccines in Chickens Regional Sales and Value Analysis
  1. 6.1 Global Coccidiosis Vaccines in Chickens Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Coccidiosis Vaccines in Chickens Sales by Region (2021-2032)
  3. 6.2.1 Global Coccidiosis Vaccines in Chickens Sales by Region: 2021-2026
  4. 6.2.2 Global Coccidiosis Vaccines in Chickens Sales by Region (2027-2032)
  5. 6.3 Global Coccidiosis Vaccines in Chickens Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Coccidiosis Vaccines in Chickens Sales Value by Region (2021-2032)
  7. 6.4.1 Global Coccidiosis Vaccines in Chickens Sales Value by Region: 2021-2026
  8. 6.4.2 Global Coccidiosis Vaccines in Chickens Sales Value by Region (2027-2032)
  9. 6.5 Global Coccidiosis Vaccines in Chickens Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Coccidiosis Vaccines in Chickens Sales Value (2021-2032)
  12. 6.6.2 North America Coccidiosis Vaccines in Chickens Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Coccidiosis Vaccines in Chickens Sales Value (2021-2032)
  15. 6.7.2 Europe Coccidiosis Vaccines in Chickens Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Coccidiosis Vaccines in Chickens Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Coccidiosis Vaccines in Chickens Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Coccidiosis Vaccines in Chickens Sales Value (2021-2032)
  21. 6.9.2 South America Coccidiosis Vaccines in Chickens Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Coccidiosis Vaccines in Chickens Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Coccidiosis Vaccines in Chickens Sales Value Share by Country, 2025 VS 2032
7 Coccidiosis Vaccines in Chickens Country-level Sales and Value Analysis
  1. 7.1 Global Coccidiosis Vaccines in Chickens Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Coccidiosis Vaccines in Chickens Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Coccidiosis Vaccines in Chickens Sales by Country (2021-2032)
  4. 7.3.1 Global Coccidiosis Vaccines in Chickens Sales by Country (2021-2026)
  5. 7.3.2 Global Coccidiosis Vaccines in Chickens Sales by Country (2027-2032)
  6. 7.4 Global Coccidiosis Vaccines in Chickens Sales Value by Country (2021-2032)
  7. 7.4.1 Global Coccidiosis Vaccines in Chickens Sales Value by Country (2021-2026)
  8. 7.4.2 Global Coccidiosis Vaccines in Chickens Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Coccidiosis Vaccines in Chickens Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Coccidiosis Vaccines in Chickens Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Coccidiosis Vaccines in Chickens Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Biopharm
  2. 8.1.1 Biopharm Company Information
  3. 8.1.2 Biopharm Business Overview
  4. 8.1.3 Biopharm Coccidiosis Vaccines in Chickens Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Biopharm Coccidiosis Vaccines in Chickens Product Portfolio
  6. 8.1.5 Biopharm Recent Developments
  7. 8.2 Bioproperties
  8. 8.2.1 Bioproperties Company Information
  9. 8.2.2 Bioproperties Business Overview
  10. 8.2.3 Bioproperties Coccidiosis Vaccines in Chickens Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bioproperties Coccidiosis Vaccines in Chickens Product Portfolio
  12. 8.2.5 Bioproperties Recent Developments
  13. 8.3 Boehringer Ingelheim
  14. 8.3.1 Boehringer Ingelheim Company Information
  15. 8.3.2 Boehringer Ingelheim Business Overview
  16. 8.3.3 Boehringer Ingelheim Coccidiosis Vaccines in Chickens Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Boehringer Ingelheim Coccidiosis Vaccines in Chickens Product Portfolio
  18. 8.3.5 Boehringer Ingelheim Recent Developments
  19. 8.4 Ceva Santé Animale
  20. 8.4.1 Ceva Santé Animale Company Information
  21. 8.4.2 Ceva Santé Animale Business Overview
  22. 8.4.3 Ceva Santé Animale Coccidiosis Vaccines in Chickens Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Ceva Santé Animale Coccidiosis Vaccines in Chickens Product Portfolio
  24. 8.4.5 Ceva Santé Animale Recent Developments
  25. 8.5 HIPRA
  26. 8.5.1 HIPRA Company Information
  27. 8.5.2 HIPRA Business Overview
  28. 8.5.3 HIPRA Coccidiosis Vaccines in Chickens Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 HIPRA Coccidiosis Vaccines in Chickens Product Portfolio
  30. 8.5.5 HIPRA Recent Developments
  31. 8.6 Huvepharma
  32. 8.6.1 Huvepharma Company Information
  33. 8.6.2 Huvepharma Business Overview
  34. 8.6.3 Huvepharma Coccidiosis Vaccines in Chickens Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Huvepharma Coccidiosis Vaccines in Chickens Product Portfolio
  36. 8.6.5 Huvepharma Recent Developments
  37. 8.7 MSD Animal Health
  38. 8.7.1 MSD Animal Health Company Information
  39. 8.7.2 MSD Animal Health Business Overview
  40. 8.7.3 MSD Animal Health Coccidiosis Vaccines in Chickens Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 MSD Animal Health Coccidiosis Vaccines in Chickens Product Portfolio
  42. 8.7.5 MSD Animal Health Recent Developments
  43. 8.8 Nisseiken
  44. 8.8.1 Nisseiken Company Information
  45. 8.8.2 Nisseiken Business Overview
  46. 8.8.3 Nisseiken Coccidiosis Vaccines in Chickens Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Nisseiken Coccidiosis Vaccines in Chickens Product Portfolio
  48. 8.8.5 Nisseiken Recent Developments
  49. 8.9 Vaxxinova
  50. 8.9.1 Vaxxinova Company Information
  51. 8.9.2 Vaxxinova Business Overview
  52. 8.9.3 Vaxxinova Coccidiosis Vaccines in Chickens Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Vaxxinova Coccidiosis Vaccines in Chickens Product Portfolio
  54. 8.9.5 Vaxxinova Recent Developments
  55. 8.10 Foshan Standard Biotech
  56. 8.10.1 Foshan Standard Biotech Company Information
  57. 8.10.2 Foshan Standard Biotech Business Overview
  58. 8.10.3 Foshan Standard Biotech Coccidiosis Vaccines in Chickens Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Foshan Standard Biotech Coccidiosis Vaccines in Chickens Product Portfolio
  60. 8.10.5 Foshan Standard Biotech Recent Developments
  61. 8.11 Hlinte
  62. 8.11.1 Hlinte Company Information
  63. 8.11.2 Hlinte Business Overview
  64. 8.11.3 Hlinte Coccidiosis Vaccines in Chickens Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Hlinte Coccidiosis Vaccines in Chickens Product Portfolio
  66. 8.11.5 Hlinte Recent Developments
  67. 8.12 Qilu Qingda Bio-Pharmaceutical
  68. 8.12.1 Qilu Qingda Bio-Pharmaceutical Company Information
  69. 8.12.2 Qilu Qingda Bio-Pharmaceutical Business Overview
  70. 8.12.3 Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines in Chickens Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Qilu Qingda Bio-Pharmaceutical Coccidiosis Vaccines in Chickens Product Portfolio
  72. 8.12.5 Qilu Qingda Bio-Pharmaceutical Recent Developments
  73. 8.13 Skystar Bio-pharm
  74. 8.13.1 Skystar Bio-pharm Company Information
  75. 8.13.2 Skystar Bio-pharm Business Overview
  76. 8.13.3 Skystar Bio-pharm Coccidiosis Vaccines in Chickens Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Skystar Bio-pharm Coccidiosis Vaccines in Chickens Product Portfolio
  78. 8.13.5 Skystar Bio-pharm Recent Developments
  79. 8.14 Guangdong Winsun Bio-pharmaceutical
  80. 8.14.1 Guangdong Winsun Bio-pharmaceutical Company Information
  81. 8.14.2 Guangdong Winsun Bio-pharmaceutical Business Overview
  82. 8.14.3 Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines in Chickens Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Guangdong Winsun Bio-pharmaceutical Coccidiosis Vaccines in Chickens Product Portfolio
  84. 8.14.5 Guangdong Winsun Bio-pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Coccidiosis Vaccines in Chickens Value Chain Analysis
  2. 9.1.1 Coccidiosis Vaccines in Chickens Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Coccidiosis Vaccines in Chickens Sales Mode & Process
  6. 9.2 Coccidiosis Vaccines in Chickens Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Coccidiosis Vaccines in Chickens Distributors
  9. 9.2.3 Coccidiosis Vaccines in Chickens Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst